# A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

> **NCT04404660** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Autolus Limited** · enrollment: 153 (actual)

## Conditions studied

- Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia

## Interventions

- **BIOLOGICAL:** AUTO1

## Key facts

- **NCT ID:** NCT04404660
- **Lead sponsor:** Autolus Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-06-03
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04404660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04404660, "A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04404660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*